A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior
British professor makes ÔthrillingÕ breakthrough for cure of rare untreatable cancer that killed his mum

A British professor has revealed that a major breakthrough has been made when it comes to treating a rare form of bone cancer.
Accenture CEO Julie SweetÕs cancer diagnosis shows how execs should share life-altering health events

In todayÕs CEO Daily: Diane Brady on how CEOs should handle a cancer diagnosis.
ItÕs working!Õ Columbus cancer center is first in Georgia to administer this new therapy

The treatment, Bi-Specific T-Cell Engager (BiTE) therapy, is showing promising results in U.S. patients with certain types of cancer, including small-cell lung cancer, lymphoma and multiple myeloma. BiTE therapy helps the immune system recognize cancer cells and destroy them.
Middle Schooler Discovers Cancer-Fighting Compound in Goose Droppings

It turns out that bacteria found in goose droppings have led scientists to find a compound that can potentially fight against cancer
Researchers develop targeted treatment for aggressive pregnancy cancer

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential for other cancers as well.
Proton therapy could be a safer way to treat cancer

Cancer is a disease that affects millions of people around the world, and treating it often involves tough decisions. One of the most common treatments is radiation therapy, which uses high-energy beams to kill cancer cells. While radiation can be effective, it often damages healthy tissues around the tumor, causing side effects like fatigue, skin […]
This Superfruit’s Seeds Can Reduce The Risk Of 6 Cancers

The juiciest revelation in recent health news.
LG, SNU say their new AI could find a cure for cancer

LG AI Research, in partnership with Seoul National University, is developing a model to predict multistate protein structures.
Moffitt Cancer Center Is First Health System in Tampa Bay Area To Receive Proton Therapy System for Cancer Treatment

TAMPA, Fla. — Moffitt Cancer Center, one of the nation’s leading cancer care and research institutions, is bringing the most advanced proton therapy system to the greater Tampa Bay area. Moffitt’s Proteus®ONE proton therapy system, supplied by IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, has left Belgium for its cross-Atlantic journey to Florida. Moffitt will be the first health system in the Tampa Bay area to begin installation of a proton therapy system with patients being treated as early as 2026.
Where Did the Passion Go?—Rethinking Adjuvant Immune Therapy for Triple-Negative Breast Cancer

mmunotherapy stands as one of the most transformative breakthroughs in modern cancer treatment. These innovative therapies target signaling pathways used by cancer cells to induce T-cell exhaustion at immune checkpoints, allowing the cancer to evade immune detection. In the last 10 years, immune checkpoint inhibitors have achieved long-lasting responses and, in some cases, even cures for cancers that once had poor prognoses.
Roche’s breast cancer entrant Itovebi bolsters clinical profile with overall survival win

Roches freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in combination with two established medicines, new survival data from the drugs pivotal phase 3 trial show.